Oseltamivir activity against avian influenza H9N2 strain with different point mutations in their neuraminidase

Taha Kumosani1, Diana Ahmadieh, Houssam Shaib

  • 1Biochemistry Department, Faculty of Science and Experimental Biochemistry Unit, King Fahad Medical Research Center, King Abdul Aziz University, P.O. Box 80216, Jeddah, Saudi Arabia.

Veterinaria Italiana
|October 13, 2015
PubMed

Insights

Oseltamivir effectively reduced avian influenza-H9N2 viral propagation in chicken embryos. However, one H9N2 mutant (M1) showed resistance due to neuraminidase mutations, highlighting evolving drug resistance in influenza viruses.

Area of Science:

  • Virology
  • Pharmacology
  • Molecular Biology

Background:

  • Avian influenza virus (AIV) poses a significant threat to poultry and public health.
  • Oseltamivir is a key antiviral medication used to manage influenza infections.
  • Understanding drug resistance mechanisms is crucial for effective antiviral therapy.

Purpose of the Study:

  • To optimize oseltamivir delivery for maximum antiviral activity against avian influenza-H9N2 in chicken embryos.
  • To assess the susceptibility of oseltamivir-treated H9N2 mutants to the drug.
  • To investigate the impact of neuraminidase mutations on oseltamivir resistance.

Main Methods:

  • Chicken embryo model used to test oseltamivir efficacy against avian influenza-H9N2 (P0 strain).
  • Optimized oseltamivir concentration (0.27 mg/100 μl) and viral inoculum (1.2 x 10⁻⁵ HA units) determined.
  • Susceptibility of four H9N2 mutants (M1-M4) to oseltamivir evaluated using the optimized protocol.

Main Results:

  • Oseltamivir achieved a 95% reduction in viral propagation (HA titer) against the P0 strain at the optimized conditions.
  • One mutant (M1) exhibited resistance to oseltamivir, showing minimal reduction in HA titer.
  • Mutants M2, M3, and M4 displayed varying sensitivity, with HA titer reductions of 82.9%, 61.5%, and 100.0%, respectively.
  • Mutant M1 resistance was linked to two adjacent point mutations in the neuraminidase (N) amino acid sequence (positions 46 and 47).

Conclusions:

  • The study successfully optimized oseltamivir delivery in chicken embryos for avian influenza-H9N2.
  • Emergence of oseltamivir-resistant H9N2 mutant (M1) identified, associated with specific neuraminidase mutations.
  • Further research is needed to elucidate the precise mechanism by which neuraminidase mutations influence H9N2 susceptibility to oseltamivir.

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.8K
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
37
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.9K